Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis
Go back to Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis| Aceto Corp (NASDAQ: ACET) | Delayed: 3.99 -0.29 (6.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.28 | 52 Week High | $28.54 | |||
| Open | $4.22 | 52 Week Low | $15.69 | |||
| Day High | $4.29 | P/E | 3.59 | |||
| Day Low | $3.96 | EPS | $1.11 | |||
| Volume | 162,965 | |||||



